KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Gains from Investment Securities (2016 - 2025)

LifeMD (LFMD) has disclosed Gains from Investment Securities for 13 consecutive years, with $104529.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities rose 101.62% year-over-year to $104529.0, compared with a TTM value of -$967186.0 through Dec 2025, down 551.51%, and an annual FY2025 reading of $587000.0, up 552.22% over the prior year.
  • Gains from Investment Securities was $104529.0 for Q4 2025 at LifeMD, down from $1.2 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $4.4 million in Q3 2024 and bottomed at -$6.5 million in Q4 2024.
  • Average Gains from Investment Securities over 5 years is $245978.9, with a median of $563000.0 recorded in 2022.
  • The sharpest move saw Gains from Investment Securities crashed 588.6% in 2022, then surged 6915.24% in 2024.
  • Year by year, Gains from Investment Securities stood at $535000.0 in 2021, then plummeted by 588.6% to -$2.6 million in 2022, then skyrocketed by 102.37% to $62053.0 in 2023, then plummeted by 10526.87% to -$6.5 million in 2024, then surged by 101.62% to $104529.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for LFMD at $104529.0 in Q4 2025, $1.2 million in Q2 2025, and $30000.0 in Q1 2025.